DealBook: Dell Nears a Buyout Deal of More Than $23 Billion

Dell Inc. neared an agreement on Monday to sell itself to a group led by its founder and the investment firm Silver Lake for more than $23 billion, people briefed on the matter said, in what would be the biggest buyout since the financial crisis.

If completed, a takeover would be the most ambitious attempt yet by Michael S. Dell to revive the company that bears his name. Such is the size of the potential deal that Mr. Dell has called upon Microsoft, one of his most important business partners, to shore up the proposal with additional financial muscle. The question will now turn to whether taking the personal computer maker private will accomplish what years of previous turnaround efforts have not.

The final details were being negotiated on Monday evening, and a deal could be announced as soon as Tuesday. Still, last-minute obstacles could cause the talks to collapse, the people briefed on the matter cautioned.

The consortium is expected to pay $13.50 to $13.75 a share, these people said. Mr. Dell is expected to contribute his nearly 16 percent stake to the deal, worth about $3.8 billion under the current set of terms. He is also expected to contribute hundreds of millions of dollars in fresh capital from his own fortune.

Silver Lake, known as one of the biggest investors in technology companies, would most likely contribute roughly $1 billion, these people added. Microsoft is expected to put in about $2 billion, though that would probably come in the form of preferred shares or debt.

Dell is also expected to bring home some of the cash that it holds in offshore accounts to help with the financing.

A spokesman for Dell declined to comment.

For decades, Dell benefited from its status as a pioneer in the market for personal computers. Founded in 1984 in a dormitory room at the University of Texas, the company grew into one of the biggest computer makers in the world, built on the simple premise that customers would flock to customize their machines.

By the late 1990s, its fast-rising stock created a company worth $100 billion and minted a class of “Dellionaires” whose holdings made for big fortunes, at least on paper. Mr. Dell amassed an estimated $16 billion and formed a quietly powerful investment firm to manage those riches.

But growing competition has sapped Dell’s strength. Rivals like Lenovo and Samsung have made the PC-making business less profitable. Last month, the market research firm Gartner reported that Dell sold 37.6 million PCs worldwide in 2012, a 12.3 percent drop from the previous year’s shipments. Perhaps more significant is the emergence of the smartphone and the tablet, two classes of devices that have eaten away at sales of traditional computers.

Mr. Dell has sought to move the company into the more lucrative and stable business of providing corporations with software services, spending billions of dollars on acquisitions to lead that transformation. The aim is to refashion Dell into something more like I.B.M. or Oracle. Even so, manufacturing PCs still makes up half of the company’s business.

The company’s stock had fallen 59 percent in the 10 years ended Jan. 11, the last business day before word of the buyout talks emerged. That has actually made Dell more tempting as a takeover target for its founder and Silver Lake, which see it as undervalued.

A Dell deal would be a watershed moment for the leveraged buyout industry: It would be the largest takeover since the Blackstone Group paid $26 billion for Hilton Hotels in the summer of 2007. No leveraged buyout since the financial crisis has surpassed the $7.2 billion that Kohlberg Kravis Roberts and others paid for the Samson Investment Company, an oil and gas driller, in the fall of 2011.

Private equity executives have hungered for the chance to strike a deal worth more than $10 billion, an accomplishment believed difficult because of the sheer size of financing required. Dell would take on more than $15 billion in debt, an enormous amount arranged by no fewer than four banks.

But the debt markets have been soaring over the last two years, as the cost of junk bonds has stayed low. Persistent low interest rates have prompted debt buyers to seek investments that carry higher yields

Dell was unusually well-placed to make a deal with private equity. The company carries $4.9 billion in long-term debt, which some analysts have regarded as a manageable amount. And its management has signaled a willingness to bring back at least some of the company’s cash hoard held overseas, despite potentially ringing up a hefty tax bill.

It is unclear whether the company’s biggest investors will accept a deal at the levels that the buyer consortium is advocating. Shares of Dell fell 2.6 percent, to $13.27, on Monday after reports of the proposed price range emerged.

Biggest Private Equity-Backed Leveraged Buyouts

DEAL, IN BILLIONSTARGETBUYERANNOUNCED
Source: Thomson Reuters *At time of deal, including assumption of debt, not adjusted for inflation.
$44.3TXUMorgan Stanley, Citigroup, Lehman Brothers Holdings, Kohlberg Kravis Roberts, Texas Pacific Group and Goldman SachsFebruary 2007
37.7Equity Office Properties TrustBlackstone GroupNovember 2006
32.1HCABain Capital, Kohlberg Kravis Roberts and Merrill Lynch Global PrivateJuly 2006
30.2RJR NabiscoKohlberg Kravis RobertsOctober 1988
30.1BAAGrupo Ferrovial SA, Caisse de Depot et Placement and GIC Special InvestMarch 2006
27.6Harrah’s EntertainmentTexas Pacific Group and Apollo ManagementOctober 2006
27.4Kinder MorganGS Capital Partners, The Carlyle Group and Riverstone HoldingsMay 2006
27.2AlltelTPG Capital and GS Capital PartnersMay 2007
27.0First DataKohlberg Kravis RobertsApril 2007
26.7Hilton HotelsBlackstone GroupJuly 2007
Read More..

'American Sniper' Chris Kyle shot dead in a post-combat world









Military sniper Chris Kyle had survived the dust-worn places where he had to worry about enemy fire — or even friendly fire — until this weekend.


Kyle, 38, an author and former Navy SEAL, was shot dead Saturday by an unemployed, 25-year-old Marine veteran, Texas officials said Sunday. Kyle's friend Chad Littlefield, 35, was also killed. No one witnessed the shootings, authorities said.


The suspect, Eddie Ray Routh, used a semiautomatic handgun to shoot Kyle and Littlefield multiple times at a secluded gun range at the Rough Creek Lodge southwest of Fort Worth, investigators said at a televised news conference. Routh is in custody and is expected to face two capital murder charges.





Routh had enlisted in the Marines in 2006, deploying to Iraq in 2007 and to Haiti in 2010 for hurricane relief. He remains in the Marine Reserve.


After Kyle left the Navy in 2009, he wrote "American Sniper: The Autobiography of the Most Lethal Sniper in U.S. Military History." During his four deployments to Iraq, he wrote, he'd recorded the most confirmed kills of any American sniper — more than 150.


Back in the States, Kyle was known to take troubled veterans to gun ranges as part of giving back — shooting and hanging out as a kind of therapy.


"The shooter is possibly one of those people," Erath County Sheriff Tommy Bryant said at the news conference, hinting that Routh's mother, a schoolteacher, may have reached out to Kyle to get help for her son. Officials couldn't confirm whether Routh had suffered from post-traumatic stress disorder.


Routh appeared to be one of the nation's numerous unemployed veterans, and Kyle was one of those who left the anonymity of military service and entered the public sphere.


Kyle's autobiography was unapologetically politically incorrect: During one visit home between deployments, he got a tattoo of a crusader cross on his arm.


"I wanted everyone to know I was a Christian," Kyle wrote. "I had it put in in red, for blood. I hated the damn savages I'd been fighting. I always will. They've taken so much from me."


Kyle won adulation and a spotlight and appeared on the NBC reality show "Stars Earn Stripes," in which "celebrities are challenged to execute complicated missions inspired by real military exercises."


In an interview last year with Fox News' Bill O'Reilly, Kyle claimed to have punched former Minnesota Gov. Jesse Ventura in 2006 for "bad-mouthing the war, bad-mouthing Bush and bad-mouthing America."


Kyle was president of Craft International, a military and law enforcement training company. In a statement lamenting the slayings, the company identified Littlefield as Kyle's trusted friend and said they died trying to help "a troubled veteran."


News of Kyle's demise spread quickly through the Navy SEAL community, according to Rorke Denver, a reserve SEAL team lieutenant commander based in San Diego, who served with Kyle on SEAL Team 3 in Iraq.


"We're such a small brotherhood that when something happens to anybody here or overseas, word travels fast," Denver said Sunday.


Denver said the news was "really hard to believe," and he called Kyle "one of our real champions and battle stars."


"I knew Chris had been working with other veterans, folks with PTSD, trying to help them get better," Denver said. "It's hard to stomach that someone he was trying to help would turn on him."


Denver said he had been fielding questions from civilians who couldn't understand why Kyle would have taken someone with PTSD to a shooting range — but as a veteran, he understands.


"That type of shooting can actually be cathartic, calming," Denver said, "letting your heart settle," particularly for veterans who have just returned home after being accustomed to carrying weapons.


Officials said they didn't have a motive for Routh's attack. The three men apparently traveled to the gun range together in the same truck.





Read More..

Wired Science Space Photo of the Day: Wheatley Crater on Venus


Magellan radar image of Wheatley crater on Venus. This 72 km diameter crater shows a radar bright ejecta pattern and a generally flat floor with some rough raised areas and faulting. The crater is located in Asteria Regio at 16.6N,267E.


Image: NASA/GSFC [high-resolution]


Caption: NASA

Read More..

The top films at the North American Box Office






LOS ANGELES (Reuters) – Following are the top 10 movies at North American box offices for the weekend starting February 1, led by Warm Bodies at No. 1, according to studio estimates compiled by Reuters. 1 (*) Warm Bodies…………………………..$ 20.0 million 2 (1) Hansel and Gretel……………………..$ 9.2 million 3 (3) Silver Linings Playbook………………..$ 8.1 million 4 (2) Mama…………………………………$ 6.7 million 5 (4) Zero Dark Thirty………………………$ 5.3 million 6 (*) Bullet to the Head…………………….$ 4.5 million 7 (5) Parker……………………………….$ 3.2 million 8 (6) Django Unchained………………………$ 3.0 million 9 (10)Les Miserables………………………..$ 2.4 million 10 (11)Lincoln………………………………$ 2.4 million NOTES: (*) = new release


CUMULATIVE TOTALS: Lincoln…………………………………..$ 170.8 million Django Unchained…………………………..$ 151.0 million Les Miserables…………………………….$ 141.5 million Silver Linings Playbook…………………….$ 80.4 million Zero Dark Thirty…………………………..$ 77.8 million Mama……………………………………..$ 58.3 million Hansel and Gretel: Witch Hunters…………….$ 34.5 million Warm Bodies……………………………….$ 20.0 million Parker……………………………………$ 12.4 million Bullet to the Head…………………………$ 4.5 million






Hansel & Gretel: Witch Hunters” was distributed by Paramount Pictures, a unit of Viacom Inc. “Zero Dark Thirty” was released by Sony Corp’s movie studio. “Warm Bodies” and “The Last Stand” were distributed by Lions Gate Entertainment. “Bullet to the Head” was released by Warner Bros, a unit of Time Warner Inc “Django Unchained” and “Silver Linings Playbook” were distributed by Weinstein Co. “Les Miserables” and “Mama” were distributed by Universal Pictures, a unit of Comcast Corp.


(Reporting By Ronald Grover and Andrea Burzynski; Editing by Sandra Maler)


Movies News Headlines – Yahoo! News





Title Post: The top films at the North American Box Office
Url Post: http://www.news.fluser.com/the-top-films-at-the-north-american-box-office/
Link To Post : The top films at the North American Box Office
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..

Medicines Co. Licenses Rights to Cholesterol Drug



The drug, known as ALN-PCS, inhibits a protein in the body known as PCSK9. Such drugs might one day be used to treat millions of people who do not achieve sufficient cholesterol-lowering from commonly used statins, such as Lipitor.


The Medicines Company will pay $25 million initially and as much as $180 million later if certain development and sales goals are met, under the deal expected to be formally announced Monday. It will also pay Alnylam, which is based in Cambridge, Mass., double-digit royalties on global sales.


That is small payment for a drug with presumably a huge potential market, probably reflecting that Alnylam is still in the first of three phases of clinical trials, well behind some far bigger competitors.


The team of Sanofi and Regeneron Pharmaceuticals is already entering the third and final stage of trials with their PCSK9 inhibitor, as is Amgen. Pfizer and Roche are in midstage trials.


ALN-PCS is different from the other drugs. It uses a gene-silencing mechanism called RNA interference, aimed at shutting off production of the PCSK9 protein. The other drugs are proteins called monoclonal antibodies that inhibit the action of PCSK9 after it has been formed.


Alnylam and the Medicines Company hope that turning off the faucet, as it were, will be more efficient than mopping the floor, allowing their drug to be given less frequently and in smaller amounts.


But that has yet to be proved. No drug using RNA interference has reached the market.


The Medicines Company, based in Parsippany, N.J., generates almost all of its revenue from one product — Angiomax, an anticlotting drug used when patients receive stents to open clogged arteries.


Dr. Clive A. Meanwell, chief executive of the company, said that PCSK9 inhibitors are likely to be used at first mainly by patients with severe lipid problems under the care of interventional cardiologists, the same doctors who use Angiomax. “It really is quite adjacent to what we do,” he said.


The Medicines Company licensed Angiomax from Biogen Idec, where the drug was invented and initially developed under a team led by Dr. John M. Maraganore, who is now the chief executive of Alnylam.


“It’s a bit like getting the band back together,” Dr. Maraganore said.


Read More..

Medicines Co. Licenses Rights to Cholesterol Drug



The drug, known as ALN-PCS, inhibits a protein in the body known as PCSK9. Such drugs might one day be used to treat millions of people who do not achieve sufficient cholesterol-lowering from commonly used statins, such as Lipitor.


The Medicines Company will pay $25 million initially and as much as $180 million later if certain development and sales goals are met, under the deal expected to be formally announced Monday. It will also pay Alnylam, which is based in Cambridge, Mass., double-digit royalties on global sales.


That is small payment for a drug with presumably a huge potential market, probably reflecting that Alnylam is still in the first of three phases of clinical trials, well behind some far bigger competitors.


The team of Sanofi and Regeneron Pharmaceuticals is already entering the third and final stage of trials with their PCSK9 inhibitor, as is Amgen. Pfizer and Roche are in midstage trials.


ALN-PCS is different from the other drugs. It uses a gene-silencing mechanism called RNA interference, aimed at shutting off production of the PCSK9 protein. The other drugs are proteins called monoclonal antibodies that inhibit the action of PCSK9 after it has been formed.


Alnylam and the Medicines Company hope that turning off the faucet, as it were, will be more efficient than mopping the floor, allowing their drug to be given less frequently and in smaller amounts.


But that has yet to be proved. No drug using RNA interference has reached the market.


The Medicines Company, based in Parsippany, N.J., generates almost all of its revenue from one product — Angiomax, an anticlotting drug used when patients receive stents to open clogged arteries.


Dr. Clive A. Meanwell, chief executive of the company, said that PCSK9 inhibitors are likely to be used at first mainly by patients with severe lipid problems under the care of interventional cardiologists, the same doctors who use Angiomax. “It really is quite adjacent to what we do,” he said.


The Medicines Company licensed Angiomax from Biogen Idec, where the drug was invented and initially developed under a team led by Dr. John M. Maraganore, who is now the chief executive of Alnylam.


“It’s a bit like getting the band back together,” Dr. Maraganore said.


Read More..

'Argo' director Ben Affleck Wins DGA Award









Ben Affleck was named outstanding director for "Argo" at the 65th Annual Directors Guild of America Awards, which were held Saturday night at the Ray Dolby Ballroom at Hollywood & Highland.


The win solidifies "Argo" as an Oscar frontrunner, after the film also claimed key honors from the Screen Actors and Producers guilds last weekend.


"I don't this makes me a real director, but I think it means I'm on my way," Affleck said in a speech.





The other nominees for the feature directing award were Kathryn Bigelow for "Zero Dark Thirty," Tom Hooper for "Les Miserables," Ang Lee for "Life of Pi" and Steven Spielberg for "Lincoln."

The DGA award for feature directing has traditionally been a reliable indicator of who will win the directing Oscar -- only six times since the DGA Awards began in 1948 have the two honors differed.


But this year's Oscar directing race has been a bit of a head-scratcher--Affleck was not nominated, despite his film receiving multiple nominations from the Academy in other categories. Bigelow and Hooper were also snubbed.


The DGA is a larger body than the Academy's directing branch, representing 15,000 members, many of them in television.


The ceremony's television winners included Rian Johnson, who earned the drama series award for directing the "Fifty-One" episode of "Breaking Bad"; Lena Dunham, who collected the comedy series award for directing the pilot of "Girls"; and Jay Roach, who took the movies for television/miniseries prize for "Game Change" on HBO.


The evening's winner for documentary directing was Malik Bendjelloul, for the "Searching For Sugarman."


A lifetime achievement award was presented to "One Flew Over the Cuckoo's Nest" and "The People vs. Larry Flynt" director Milos Forman.


Host Kelsey Grammer kept the evening light, making jokes about Manti Te'o, Mel Gibson and Ron Jeremy, as well as some of the nominees in the room.


Grammer said to Bigelow, whose movie has been at the center of a controversy over forced interrogation, "Waiting so patiently to see if your name will be called, it must be torture for you."


All of the evening's feature directing nominees received a medallion from the DGA, most of them presented after an adoring speech. Martin Short, however, delivered Spielberg's medallion in an irreverent and sometimes bawdy address.


"I like my champagne like I like my women," Short said. "Compliments of the DGA."


When Spielberg stood to accept the honor--receiving the night's first full-house standing ovation--he reacted with amusement.


"When you tell your assistant to contact Marty about presenting you with the DGA medallion," Spielberg said, "You just assume she knows you're talking about Marty Scorsese."


ALSO


Academy doesn't follow the script in directors' race


Santa Barbara Film Fest sees itself as Oscar harbinger


Is 'Argo' poised to deliver a shocker at Directors Guild Awards?





Read More..

The World's Tweets Light Up the Globe in Stunning Live Visualization




It’s simple, but lovely. Web designer Franck Ernewein‘s real-time Twitter visualization, Tweetping, drops a bright pixel at the location of every tweet in the world, starting as soon as you open the page.



The result is a constantly changing image that grows to look like a nighttime satellite shot, bright spots swarming over the most developed areas. But Ernewein has packaged it all in a subtly interactive visualization that avoids distracting the viewer while still imparting a great amount of information.



Meanwhile, a selection of tweets are projected, along with latest hashtags and mentions, all while tracking total tweets, words, and characters. The length of the two gray lines on the display represent the number of characters and words in each tweet.



Though it’s one of the most beautiful, Tweetping is far from the first to display geotagged tweet information; coders have built sites to display election tweets, adjustable parameter maps, and even 3-D visualizations.



Tweetping even represents Antarctica, but not the ISS. And there’s no pause button; like Twitter itself, Tweetping’s data accrues incessantly; there’s no off switch but the back button.





Read More..

‘Girls,’ ‘Sugar Man’ earn Directors Guild honors






LOS ANGELES (AP) — “Girls” star Lena Dunham has won the TV comedy directing prize from the Directors Guild of America, while the musical portrait “Searching for Sugar Man” earned the documentary award.


Dunham won Saturday for directing the pilot of the show, which focuses on the lives of a group of girls in their 20s.






“It is such an unbelievable honor to be in the company of the people in this room, who have made me want to do this with my life,” Dunham said.


Malik Bendjelloul won the documentary award for “Sugar Man,” his study of the fate of critically acclaimed but obscure 1970s singer-songwriter Rodriquez. The film also is nominated for best documentary at the Feb. 24 Academy Awards.


Among other early TV winners:


— Musical variety: Glenn Weiss, “The 66th Annual Tony Awards.”


— Daytime serial: Jill Mitwell, “One Life to Live.”


— Children’s program: Paul Hoen, “Let It Shine.”


The Directors Guild honors continued Hollywood’s strange awards season, which could culminate with a big Oscar win for Ben Affleck‘s “Argo.” The guild’s prize for best director typically is a final blessing for the film that goes on to win best-picture and director at the Academy Awards.


Affleck can go only one-for-two at the Oscars, though. He’s up for the film honor at the Directors Guild, and “Argo” is looking like the best-picture favorite at the Oscars. But the director’s branch of the Academy of Motion Picture Arts and Sciences overlooked him and several other key filmmakers for an Oscar directing slot.


The guild and Oscar directing lineups usually match up closely, but they have little in common this season, with only Steven Spielberg for “Lincoln” and Ang Lee for “Life of Pi” nominated at both shows.


Along with them and Affleck, the guild nominated Kathryn Bigelow for “Zero Dark Thirty” and Tom Hooper for “Les Miserables.” At the Oscars, Spielberg and Lee are joined in the directing category by Michael Haneke for “Amour,” David O. Russell for “Silver Linings Playbook” and Benh Zeitlin for “Beasts of the Southern Wild.”


Director Norman Jewison, the guild’s 2010 lifetime-achievement prize winner, presented Bigelow with her nomination plaque and noted the incongruity of the Oscar best-picture field, which has nine nominees, while there are only five directing slots.


“So apparently, there were four films that were directed by themselves,” Jewison said.


With 12 Oscar nominations, Spielberg’s Civil War saga initially looked like the Oscar favorite over such other potential favorites as “Argo,” ”Les Miserables” and “Zero Dark Thirty,” since films generally have little chance of winning best picture if they are not nominated for best director. Only three films have done it in 84 years, most recently 1989′s best-picture champ “Driving Miss Daisy,” which failed to earn a directing nomination for Bruce Beresford.


But Affleck’s “Argo,” in which he also stars as a CIA operative who hatches a bold plan to rescue six Americans during the hostage crisis in Iran, has swept up all the major awards since the Oscar nominations. “Argo” won best drama and director at the Golden Globes and top film honors from the Screen Actors Guild and the Producers Guild of America.


Many of the same film professionals who vote in guild awards also cast ballots for the Oscars. If Affleck wins at the Directors Guild awards, it will be a strong sign that “Argo” has the inside track for the best-picture Oscar.


Affleck may have a bit of newcomer’s edge at the guild, where he’s the only first-time nominee. Spielberg has won the guild prize a record three times, for “The Color Purple,” ”Schindler’s List” and “Saving Private Ryan.” Lee has won twice, for “Crouching Tiger, Hidden Dragon” and “Brokeback Mountain,” while Bigelow won three years ago for “The Hurt Locker” and Hooper won two years ago for “The King’s Speech.”


A win for Affleck would nick the guild’s record as a strong forecast for the eventual directing recipient at the Oscars. Only six times in the 64-year history of the guild awards has the winner there failed to follow up with an Oscar. It would be No. 7 if Affleck wins Saturday, since he’s not up for best director at the Oscars.


Peer loyalty might play in Affleck’s favor at the Oscars. The acting branch in particular, the largest block of the academy’s 5,900 members, might really throw its weight behind “Argo” because of Affleck’s directing snub. Actors love it when one of their own moves into a successful directing career, and Affleck — who’s rarely earned raves for his dramatic chops — also delivers one of his best performances in “Argo.”


Affleck has had no traction in acting honors this season, and he’s joked that no one considered it a snub when he wasn’t nominated for best actor. So a best-picture vote for “Argo” might be viewed as making right his omission from the directing lineup and acknowledging what a double-threat talent he’s become in front of and behind the camera.


A best-picture prize also would send Affleck home with an Oscar. The award would go to the producers of “Argo”: George Clooney, Grant Heslov and Affleck.


But it’s not as though Affleck has never gotten his due at Hollywood awards before. He and Matt Damon jump-started their careers with 1997′s “Good Will Hunting,” for which they shared a screenplay Oscar.


___


AP Entertainment Writer Sandy Cohen contributed to this report.


Entertainment News Headlines – Yahoo! News





Title Post: ‘Girls,’ ‘Sugar Man’ earn Directors Guild honors
Url Post: http://www.news.fluser.com/girls-sugar-man-earn-directors-guild-honors/
Link To Post : ‘Girls,’ ‘Sugar Man’ earn Directors Guild honors
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..

Concerns About A.D.H.D. Practices and Amphetamine Addiction


Before his addiction, Richard Fee was a popular college class president and aspiring medical student. "You keep giving Adderall to my son, you're going to kill him," said Rick Fee, Richard's father, to one of his son's doctors.







VIRGINIA BEACH — Every morning on her way to work, Kathy Fee holds her breath as she drives past the squat brick building that houses Dominion Psychiatric Associates.










Andrea Mohin/The New York Times

MENTAL HEALTH CLINIC Dominion Psychiatric Associates in Virginia Beach, where Richard Fee was treated by Dr. Waldo M. Ellison. After observing Richard and hearing his complaints about concentration, Dr. Ellison diagnosed attention deficit hyperactivity disorder and prescribed the stimulant Adderall.






It was there that her son, Richard, visited a doctor and received prescriptions for Adderall, an amphetamine-based medication for attention deficit hyperactivity disorder. It was in the parking lot that she insisted to Richard that he did not have A.D.H.D., not as a child and not now as a 24-year-old college graduate, and that he was getting dangerously addicted to the medication. It was inside the building that her husband, Rick, implored Richard’s doctor to stop prescribing him Adderall, warning, “You’re going to kill him.”


It was where, after becoming violently delusional and spending a week in a psychiatric hospital in 2011, Richard met with his doctor and received prescriptions for 90 more days of Adderall. He hanged himself in his bedroom closet two weeks after they expired.


The story of Richard Fee, an athletic, personable college class president and aspiring medical student, highlights widespread failings in the system through which five million Americans take medication for A.D.H.D., doctors and other experts said.


Medications like Adderall can markedly improve the lives of children and others with the disorder. But the tunnel-like focus the medicines provide has led growing numbers of teenagers and young adults to fake symptoms to obtain steady prescriptions for highly addictive medications that carry serious psychological dangers. These efforts are facilitated by a segment of doctors who skip established diagnostic procedures, renew prescriptions reflexively and spend too little time with patients to accurately monitor side effects.


Richard Fee’s experience included it all. Conversations with friends and family members and a review of detailed medical records depict an intelligent and articulate young man lying to doctor after doctor, physicians issuing hasty diagnoses, and psychiatrists continuing to prescribe medication — even increasing dosages — despite evidence of his growing addiction and psychiatric breakdown.


Very few people who misuse stimulants devolve into psychotic or suicidal addicts. But even one of Richard’s own physicians, Dr. Charles Parker, characterized his case as a virtual textbook for ways that A.D.H.D. practices can fail patients, particularly young adults. “We have a significant travesty being done in this country with how the diagnosis is being made and the meds are being administered,” said Dr. Parker, a psychiatrist in Virginia Beach. “I think it’s an abnegation of trust. The public needs to say this is totally unacceptable and walk out.”


Young adults are by far the fastest-growing segment of people taking A.D.H.D medications. Nearly 14 million monthly prescriptions for the condition were written for Americans ages 20 to 39 in 2011, two and a half times the 5.6 million just four years before, according to the data company I.M.S. Health. While this rise is generally attributed to the maturing of adolescents who have A.D.H.D. into young adults — combined with a greater recognition of adult A.D.H.D. in general — many experts caution that savvy college graduates, freed of parental oversight, can legally and easily obtain stimulant prescriptions from obliging doctors.


“Any step along the way, someone could have helped him — they were just handing out drugs,” said Richard’s father. Emphasizing that he had no intention of bringing legal action against any of the doctors involved, Mr. Fee said: “People have to know that kids are out there getting these drugs and getting addicted to them. And doctors are helping them do it.”


“...when he was in elementary school he fidgeted, daydreamed and got A’s. he has been an A-B student until mid college when he became scattered and he wandered while reading He never had to study. Presently without medication, his mind thinks most of the time, he procrastinated, he multitasks not finishing in a timely manner.”


Dr. Waldo M. Ellison


Richard Fee initial evaluation


Feb. 5, 2010


Richard began acting strangely soon after moving back home in late 2009, his parents said. He stayed up for days at a time, went from gregarious to grumpy and back, and scrawled compulsively in notebooks. His father, while trying to add Richard to his health insurance policy, learned that he was taking Vyvanse for A.D.H.D.


Richard explained to him that he had been having trouble concentrating while studying for medical school entrance exams the previous year and that he had seen a doctor and received a diagnosis. His father reacted with surprise. Richard had never shown any A.D.H.D. symptoms his entire life, from nursery school through high school, when he was awarded a full academic scholarship to Greensboro College in North Carolina. Mr. Fee also expressed concerns about the safety of his son’s taking daily amphetamines for a condition he might not have.


“The doctor wouldn’t give me anything that’s bad for me,” Mr. Fee recalled his son saying that day. “I’m not buying it on the street corner.”


Read More..